Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.7K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Tumor Immunotherapy01:27

Tumor Immunotherapy

1.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.5K
Cancer Therapies02:49

Cancer Therapies

9.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K
Cancer Vaccines01:30

Cancer Vaccines

857
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
857

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatially defined microenvironmental niches are associated with clinical outcome and tumor ecosystem diversity in head and neck cancer.

Med (New York, N.Y.)·2026
Same author

CanAssist Breast Risk Stratification in Multifocal/Multicentric Breast Cancer: To Test Each Focus or Not?

Archives of pathology & laboratory medicine·2026
Same author

Benzazepines Derivatives: Synthetic Strategy, Structural-Activity Relationships, and Medical Potential as Dopamine and Serotonin Receptor Modulators.

ACS omega·2026
Same author

Rapid Transcription Dynamics Confers Cytarabine Resistance in Acute Myeloid Leukemia.

Blood cancer discovery·2026
Same author

Synthesis and Biological Activity of Guanidine Scaffold: A Comprehensive Review.

Anti-inflammatory & anti-allergy agents in medicinal chemistry·2026
Same author

Pseudo-autologous Stem Cell Transplant for the Treatment of Secondary Central Nervous System Lymphoma.

Cureus·2026
Same journal

Unveiling the Potential of Drug Delivery Systems for Tyrosine Kinase Inhibitors in the Treatment of Neovascular Eye Diseases.

Critical reviews in therapeutic drug carrier systems·2026
Same journal

Investigation of Bioinspired Nanocurcumin Composites for Antibacterial Applications.

Critical reviews in therapeutic drug carrier systems·2026
Same journal

Advances in the Preparation of Lipid-Based Nanotechnologies: Expanding the Horizons of Therapeutic Applications.

Critical reviews in therapeutic drug carrier systems·2026
Same journal

Nano Lipid Carriers (NLCs): Potential and Promises in Drug Delivery.

Critical reviews in therapeutic drug carrier systems·2026
Same journal

CpG ODNs: Precision Immunotherapy and Recent Trends in Nano-Enabled Nucleotide Delivery.

Critical reviews in therapeutic drug carrier systems·2026
Same journal

Plant-Based Exosomes: Insights and Therapeutic Applications.

Critical reviews in therapeutic drug carrier systems·2026
See all related articles

Related Experiment Video

Updated: Dec 10, 2025

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

11.3K

Combination Cancer Therapy Using Multifunctional Liposomes.

Ankit Jain1, Ankita Tiwari2, Amit Verma2

  • 1Institute of Pharmaceutical Research, GLA University, 17km Stone, NH-2, Mathura-Delhi Road P.O. Chaumuhan, Mathura, Uttar Pradesh 281406, India.

Critical Reviews in Therapeutic Drug Carrier Systems
|September 1, 2020
PubMed
Summary
This summary is machine-generated.

Liposomes offer enhanced cancer chemotherapy by co-delivering multiple drugs, improving efficacy and reducing side effects. This nanodrug delivery system (NDDS) shows promise for long-term cancer treatment.

More Related Videos

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
07:32

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

11.8K
Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

11.4K

Related Experiment Videos

Last Updated: Dec 10, 2025

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

11.3K
Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
07:32

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

11.8K
Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

11.4K

Area of Science:

  • Oncology
  • Nanotechnology
  • Pharmacology

Background:

  • Single-agent chemotherapy faces limitations due to drug resistance and severe side effects.
  • Nanodrug delivery systems (NDDSs) are explored to improve anticancer agent safety and efficacy.
  • Single-agent NDDSs are insufficient for long-term cancer therapy.

Purpose of the Study:

  • To review recent advancements in liposome-based combinatorial drug delivery for improved chemotherapy.
  • To highlight the potential of co-delivering multiple anticancer agents using liposomes.

Main Methods:

  • Review of literature on liposome-based combinatorial drug delivery systems.
  • Analysis of studies reporting combinations of anticancer drugs encapsulated in liposomes.
  • Focus on synergistic effects, low-dose requirements, and reduced side effects.

Main Results:

  • Liposomes effectively co-deliver both hydrophobic and hydrophilic anticancer drugs.
  • Combinatorial liposomal delivery demonstrates synergistic therapeutic effects at the tumor site.
  • This approach enhances therapeutic efficacy, reduces the required dose of each agent, and diminishes side effects.

Conclusions:

  • Liposomes are versatile nanocarriers for combinatorial drug delivery in cancer chemotherapy.
  • Co-delivery using liposomes offers significant advantages, including enhanced blood circulation and tumor targeting.
  • This strategy holds great importance for developing novel drug delivery approaches for better cancer treatment outcomes.